While endurance running is widely celebrated for its health benefits, a trailblazing study led by Tim Cannon, MD, Sheridan Director of the Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising link to colon cancer risk. Featured in Runner’s World, the research opens important conversations around screening guidelines and reinforces the importance of proactive health monitoring, regardless of one’s fitness level.
Article links:
David Gordon, MD is a primary care is a primary care physician at Inova 360°…
Inova Schar Cancer is Northern Virginia’s only FACT-accredited health system https://vimeo.com/1158428376 There is an exciting…
More than three years after a stage IV metastatic breast cancer diagnosis, Amy’s scans are…
Inova ranks #32 in the country for Neonatology Fairfax, Virginia – Inova L.J. Murphy Children’s…
When Amal felt a sudden crack in her back while playing tennis at age 49,…
Colleen with her husband, Scott, in Great Smoky Mountains National Park. Since her diagnosis at…